Posttranslational Modifications of Red Blood Cell Ghost Proteins as “Signatures” for Distinguishing between Low- and High-Risk Myelodysplastic Syndrome Patients [Turk J Hematol]
Turk J Hematol. 2017; 34(1): 111-113 | DOI: 10.4274/tjh.2016.0251  

Posttranslational Modifications of Red Blood Cell Ghost Proteins as “Signatures” for Distinguishing between Low- and High-Risk Myelodysplastic Syndrome Patients

Klara Pecankova, Pavel Majek, Jaroslav Cermak, Jan E. Dyr
Institute of Hematology and Blood Transfusion, Prague, Czech Republic

Keywords: Myelodysplastic syndromes, Proteomics, Red blood cell ghosts, Posttranslational modifications, Erythrocytes, Electrophoresis


Düşük ve Yüksek Risk Miyelodisplastik Sendrom Hastalarını Ayıran “İşaretler” Olarak Kırmızı Kan Hücre Zarı Proteinlerinin Posttranslasyonel Modifikasyonları

Klara Pecankova, Pavel Majek, Jaroslav Cermak, Jan E. Dyr
Institute of Hematology and Blood Transfusion, Prague, Czech Republic

Anahtar Kelimeler: Miyelodisplastik sendrom, Proteomik, Kırmızı kan hücre zarı, Posttranslasyonel modifikasyon, Eritrosit, Elektroforez


Klara Pecankova, Pavel Majek, Jaroslav Cermak, Jan E. Dyr. Posttranslational Modifications of Red Blood Cell Ghost Proteins as “Signatures” for Distinguishing between Low- and High-Risk Myelodysplastic Syndrome Patients. Turk J Hematol. 2017; 34(1): 111-113

Corresponding Author: Klara Pecankova, Türkiye


TOOLS
Full Text PDF
Print
Download citation
RIS
EndNote
BibTex
Medlars
Procite
Reference Manager
Share with email
Share
Send email to author

Similar articles
PubMed
Google Scholar


 



Impact Factor (2015) = 0.827